Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABHD14A-ACY1		ENSG00000114786	"ABHD14A-ACY1 readthrough"		3	51974706-51989183	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 3.7;Club cells: 3.4;Collecting duct cells: 5.2;Distal tubular cells: 3.3;Proximal tubular cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 3.4;HUVEC TERT2: 4.2;SH-SY5Y: 3.4"									"HPA036174, HPA036175, HPA038153"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.90e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.11e-4)"	2.7	2.9	3.5	2.6	8.2	2.0	2.3	8.3	15.1	3.7	3.5	3.2	1.9	4.8	2.5	3.2	2.0	3.3	3.5	4.8	3.2	4.1	5.8	8.4	3.0	1.9	2.7	7.2	2.7	4.6	1.4	3.7	1.7	5.6	2.8	1.6	8.2	4.1	2.2	8.0	2.0	10.5	2.0	3.9	3.3	2.6	2.2	1.3	0.9	4.7	1.8	2.8	2.3	2.7	2.4	5.2	1.2	4.0	4.7	4.1	2.7	0.0	0.0	0.3	0.5	2.0	1.1	0.2	0.0	2.0	0.4	0.4	2.0	3.4	0.8	0.1	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.1	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.5	4.2	1.1	2.1	0.0	0.0	0.0	2.0	1.5	1.3	1.0	1.8	0.5	0.0	0.2	0.0	0.0	0.4	3.4	0.0	2.4	0.0	0.0	0.9	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.0	2.0	1.6	0.0	0.0	0.2	1.7	1.2	4.1	4.0	2.4	2.4	2.3	4.1	5.2	1.7	2.1	2.7	0.0	4.7	2.0	2.4	2.5	2.7	3.5	8.2	8.3	15.1	3.2	4.1	2.7	7.2	5.6	1.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.2	0.0	0.0	3.3	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	1.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011462.1		ENSG00000255730			19	41350853-41425001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 24.8"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 2: 1.7;Ciliated cells: 1.4;granulocytes: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"basal ganglia: 19.9"	"Cell type enhanced"	"Detected in many"		"classical monocyte: 24.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.3;SK-MEL-30: 8.3;THP-1: 14.7"					"Low region specificity"	"Detected in all"			HPA036640	Approved					NA	NA					"HPA036640: AB_10671964"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-1)"			"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"		"unprognostic (2.65e-1)"		"unprognostic (3.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-8)"	"unprognostic (8.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.97e-2)"	5.0	5.8	1.7	6.2	19.9	10.5	3.6	1.5	8.0	6.6	3.5	0.8	0.6	1.3	5.4	2.1	3.9	5.3	0.7	3.1	1.5	2.6	4.7	3.3	5.9	3.8	2.4	2.9	3.1	3.5	3.3	3.1	2.5	3.1	5.5	0.7	2.3	1.7	1.9	9.0	9.2	1.9	5.4	2.3	4.5	2.5	7.3	2.6	0.0	2.9	1.7	3.2	10.5	7.5	1.0	11.8	8.2	24.8	1.4	5.6	15.7	3.0	0.0	5.9	2.5	1.6	0.2	1.7	1.7	1.4	0.8	0.0	0.0	3.9	0.0	3.2	2.1	1.9	0.1	0.0	0.9	1.2	1.6	1.6	3.9	0.1	1.1	4.8	0.7	0.4	3.8	3.6	1.5	7.6	9.3	2.8	0.0	0.9	5.6	0.0	0.0	4.2	5.1	0.8	0.0	0.0	1.7	0.0	0.3	0.5	0.0	0.0	3.7	0.8	0.0	8.3	2.8	1.1	14.7	0.5	0.0	2.8	0.4	0.0	4.7	0.0	0.1	1.8	3.8	0.1	6.2	24.8	1.5	3.9	9.2	4.3	0.6	3.7	2.9	11.8	1.0	5.6	3.1	8.2	1.4	7.2	8.1	4.0	15.7	1.7	19.9	1.5	5.0	1.5	2.6	2.4	2.9	3.1	2.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 70.2;Erythroid cells: 23.3;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.8	9.0	12.1	12.8	4.2	7.9	9.3	5.1	12.4	20.8	2.5	3.5	7.3	3.4	4.9	4.0	25.6	3.7	6.9	5.1	8.9	4.6	38.3	16.6	6.0	5.8	14.0	21.2	8.2	22.1	7.6	3.5	4.4	13.4	7.9	9.1	11.1	0.0	11.0	5.7	25.3	13.6	3.1	3.3	22.5	24.3	15.0	5.5	5.0	5.3	17.5	9.2	1.6	14.1	7.9	1.7	6.7	6.4	8.3	4.9	20.9	4.9	3.8	7.8	12.5	8.0	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7	3.0	2.7	0.8	0.8	0.6	0.0	0.1	2.5	2.7	3.4	5.2	0.0	3.3	8.3	12.2	0.2	0.5	70.2	23.3	7.4	3.7	0.8	0.5	6.9	10.9	1.7	0.0	2.4	1.8	2.1	0.4	0.6	2.4	0.0	16.2	9.3	0.8	12.6	21.0	0.0	35.6	0.9	0.0	0.5	0.0	0.2	0.4	3.4	1.5	12.1	0.3
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	4.6	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	9.7	17.2	8.4	13.1	10.0	21.5	27.1	6.1	32.1	11.6	27.4	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	8.2	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9	62.5	87.9	109.0	118.8	67.5	8.0	255.0	285.3	33.5	56.9	144.8	13.7	343.4	752.7	121.5	6.7	56.4	182.2	46.7	76.6	194.2	104.6	159.8	40.5	1079.9	211.6	7.9	54.8	164.5	143.1	16.8	126.8	60.1	194.0	117.2	123.2	123.6	76.7	181.4	197.7	1041.1	13.1	161.7	119.7	4.6	8.9	67.1	319.0	55.1	135.6	117.6
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		3900000	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	15.3	18.6	11.7	15.4	15.0	17.0	24.3	6.3	16.4	25.1	30.0	14.7	18.4	24.6	20.2	23.9	43.4	26.6	22.4	26.0	12.0	12.8	52.2	99.8	19.1	18.1	16.0	10.6	39.1	72.0	15.7	15.0	44.5	13.2	26.9	20.2	14.4	32.4	18.3	48.2	14.8	20.4	18.8	15.7	17.9	22.2	33.3	13.4	25.0	52.8	31.0	29.2	18.2	20.5	9.1	24.1	2.3	26.0	4.6	7.4	11.4	37.4	49.1	20.8	36.7	24.3	26.2	23.9	15.4	22.1	34.3	27.3	132.5	32.4	58.3	27.5	19.7	22.2	43.0	48.9	86.4	22.1	7.7	29.7	70.3	24.4	85.2	26.2	32.8	23.1	54.2	39.4	21.3	34.3	18.4	23.4	21.7	34.2	14.8	18.2	39.6	42.8	31.0	26.7	48.0	47.9	32.2	53.0	41.0	30.7	26.6	36.1	24.0	30.7	36.5	51.0	17.2	54.8	30.6	14.8	29.9	31.9	15.1	29.0	22.1	32.3	35.1	22.0	20.3	15.9	2.3	13.7	0.4	4.1	26.0	6.7	9.1	6.0	5.3	21.1	7.8	6.6	7.4	1.1	4.6	16.5	24.1	6.7	11.4	11.7	15.0	6.3	16.4	12.0	12.8	16.0	10.6	13.2	13.4	38.7	21.0	33.5	72.2	32.5	11.9	44.7	25.5	17.4	29.6	26.2	0.0	93.3	49.7	60.3	58.3	23.6	33.8	0.0	70.9	130.4	41.1	68.4	20.7	56.7	103.0	11.1	20.2	16.5	33.2	135.4	39.4	28.0	25.3	26.2	64.7	41.2	59.2	24.6	38.2	192.2	10.2	12.9	38.1	20.7	47.5	34.5	76.9	18.5	111.0	66.8
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984686-110023741	"Predicted intracellular proteins"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	24.0	25.7	61.7	11.7	71.2	4.8	19.7	33.2	61.4	26.7	26.3	47.7	17.7	46.5	21.0	36.0	18.3	28.0	24.7	13.9	51.6	57.2	38.6	25.4	16.5	10.5	72.3	49.9	17.6	27.1	53.0	16.3	20.6	55.7	17.3	19.7	9.7	17.9	25.8	27.1	14.2	22.9	21.8	48.8	12.1	19.6	10.2	47.5	6.8	28.6	8.6	13.4	16.7	15.3	8.0	6.2	8.7	9.3	3.9	8.2	3.7	22.7	19.4	18.3	18.9	44.3	26.1	30.2	18.1	20.5	17.2	17.0	15.0	13.2	9.7	15.5	26.7	13.1	14.7	16.2	20.7	22.8	81.2	14.0	16.0	25.2	15.8	46.0	13.7	11.3	26.6	13.1	21.4	31.4	42.0	21.6	16.5	11.5	19.7	17.7	18.1	11.4	6.8	21.6	32.2	15.0	12.4	38.1	10.7	37.6	23.1	17.9	11.6	28.1	33.7	37.7	29.2	18.0	13.8	18.6	16.6	16.3	19.5	16.0	16.3	6.7	8.3	34.1	15.1	33.8	5.0	8.8	7.7	4.3	9.3	4.4	6.8	4.4	5.7	6.2	8.0	4.6	4.4	8.7	3.9	6.3	5.7	8.2	3.7	61.7	71.2	33.2	51.5	51.6	57.2	72.3	49.9	55.7	47.5	32.8	64.0	27.3	82.1	79.2	59.7	41.9	107.0	33.5	34.2	111.7	210.1	72.2	106.1	110.2	22.2	52.0	80.5	23.3	97.7	41.1	77.1	89.9	31.1	135.4	38.2	60.4	82.1	64.4	67.4	22.3	86.6	50.2	59.1	34.3	66.6	96.8	88.6	38.6	76.7	118.7	100.2	45.3	90.1	25.8	13.5	94.7	83.9	28.0	71.2	97.0
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.7	4.3	8.3	4.9	2.2	3.3	1.7	2.1	3.0	2.4	2.2	2.5	1.8	1.6	2.2	2.3	5.2	1.9	4.1	3.4	2.7	73.5	5.1	3.9	4.8	2.0	1.3	2.8	5.0	3.0	4.4	1.9	3.0	4.1	4.8	3.2	1.7	9.3	3.1	2.5	4.2	3.7	4.1	2.7	3.0	2.8	2.2	4.4	4.9	3.6	3.8	2.4	4.9	2.1	2.9	7.2	2.0	2.1	2.7	2.1	1.2	5.5	2.2	3.9	4.4	2.2	5.4	3.1	3.2	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6	56.6	75.8	3.4	4.5	13.9	9.4	4.5	17.8	5.3	19.4	5.2	5.9	8.4	10.0	3.6	61.0	3.9	114.1	0.0	4.9	2.2	3.1	6.2	5.7	4.9	3.9	4.8	8.7	4.3	8.3	20.3	3.7	5.1	23.6	7.2	29.7	87.7	4.5	30.8	6.3	15.7	5.0	6.5	1.2	4.6	2.4	8.5	12.7	3.2	32.7	13.9
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916499	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	23.2	29.8	12.0	13.7	18.7	9.6	15.8	7.6	12.6	12.7	13.8	17.9	16.8	10.5	15.3	10.8	12.2	13.9	12.1	15.4	14.5	11.7	24.8	21.8	16.2	14.4	21.5	11.7	13.2	19.7	13.4	10.3	12.5	21.1	14.1	12.6	10.4	18.5	20.4	48.7	6.8	13.9	16.0	27.8	13.9	19.1	9.7	21.1	23.9	19.0	12.9	11.5	19.0	16.1	14.2	25.6	14.9	19.8	17.5	15.8	10.6	8.6	9.3	11.0	2.6	9.0	9.0	4.9	12.8	12.3	12.6	14.4	5.5	7.6	26.6	7.8	4.7	13.0	10.4	20.1	8.6	16.3	16.3	19.1	13.7	9.9	13.9	13.9	38.0	10.5	8.8	6.4	8.0	13.2	5.6	10.3	15.5	32.2	16.4	8.7	8.3	18.1	17.5	8.8	11.8	22.0	11.7	32.3	9.1	13.0	12.5	9.3	4.5	16.1	12.9	15.7	5.5	13.5	11.8	8.6	9.5	9.6	24.3	3.1	16.1	12.0	30.0	11.8	8.1	12.1	4.7	16.9	14.9	11.0	17.5	13.6	14.2	13.4	11.9	25.6	13.4	13.8	11.7	4.1	17.5	19.8	16.5	15.8	10.6	12.0	18.7	7.6	12.6	14.5	11.7	21.5	11.7	21.1	21.1	32.8	26.7	21.4	29.7	22.1	22.7	19.8	40.8	48.2	28.4	17.4	3.9	31.1	159.2	23.6	5.4	20.4	30.7	23.3	28.4	20.1	20.0	35.6	19.7	21.2	67.0	17.5	34.1	22.1	46.7	7.4	22.2	39.5	20.3	66.7	30.2	16.6	21.6	24.6	23.3	70.8	21.9	38.8	25.8	22.8	24.0	23.1	22.1	24.1	38.3	41.1
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 67.1"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.0"	"Group enriched"	"Detected in some"	5	"BEWO: 17.0;CAPAN-2: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	0.0	0.2	8.8	0.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.5	1.2	15.4	1.1	0.1	0.0	0.0		0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	6.1	67.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.8	10.5	0.0	0.1	1.6	0.8	0.2	0.1	0.4	11.0	1.9	0.7	0.0	0.9	0.2	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	5.5	0.4	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	2.0	0.5	0.7	0.0	1.5	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	1.3	0.0	1.2	1.1	6.0	1.6	0.0	1.6	11.0	4.1	0.0	0.4	0.1	0.8	5.9	1.9											0.0	0.0	3.2	0.2	0.0	1.7	1.1	0.0	16.0	0.0	0.0	0.0	6.6	0.0	0.3	27.7	1.0	0.0	0.0	0.2	2.3	0.0	0.3	14.9	0.0	1.7	0.0	0.0	3.7	0.0	21.7	0.6	0.2	0.0	0.0	0.0	0.5	2.4	0.0	0.7	0.0	0.4	0.0	0.2	16.9	10.4	0.3	96.6	2.2	0.0	1.1
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1, alpha polypeptide"	P12694	19	41397460-41425005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 13.3;Ductal cells: 12.3;monocytes: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 49.4"	"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA					"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	18.4	36.1	11.5	9.2	14.9	11.4	12.9	9.3	19.3	12.5	11.2	16.6	25.0	11.2	11.0	11.2	31.0	15.0	12.4	41.1	10.8	9.5	23.4	47.6	12.3	17.0	16.0	17.6	13.8	28.2	15.7	12.6	13.4	12.7	12.6	8.8	15.0	23.1	31.1	61.7	15.6	10.4	10.8	11.2	13.2	22.0	21.2	13.5	15.8	21.8	25.3	15.9	14.0	15.1	16.5	45.9	17.6	38.0	25.9	19.7	27.1	14.4	26.5	2.3	14.2	6.6	4.1	6.1	3.5	6.8	7.0	8.9	6.0	10.0	11.7	8.0	3.8	2.8	5.8	4.4	7.2	3.7	12.2	12.7	8.1	13.8	5.7	14.3	8.5	6.0	7.3	10.4	4.7	10.3	7.8	13.4	15.6	8.1	22.0	6.3	13.0	7.3	5.1	4.0	17.4	6.6	8.8	7.9	27.7	9.8	6.8	10.3	12.4	12.5	28.6	8.7	3.3	14.6	22.9	10.1	7.5	7.7	4.3	7.6	49.4	19.9	11.4	27.1	15.9	8.7	13.5	36.9	17.6	15.8	38.0	18.2	16.5	15.9	16.1	45.9	16.4	13.4	15.3	10.9	25.9	26.1	17.6	19.7	27.1	11.5	14.9	9.3	19.3	10.8	9.5	16.0	17.6	12.7	13.5	0.0	13.3	0.5	0.0	0.2	0.0	0.0	0.0	1.4	6.8	5.2	0.0	1.6	3.3	12.3	0.6	0.6	3.4	0.0	10.3	1.6	0.8	0.0	4.7	2.1	2.5	0.0	5.8	3.1	4.1	0.4	0.6	1.2	3.3	15.4	5.3	0.4	9.4	2.9	0.4	1.6	1.2	0.0	0.4	1.7	0.9	0.6	1.7	0.0	6.4	0.0
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 56.4;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	7.0	2.6	10.0	13.4	10.2	8.9	8.0	5.0	10.4	8.3	11.4	4.3	9.7	20.0	5.4	12.0	9.7	7.1	5.5	6.6	11.6	24.8	8.2	9.9	6.9	5.8	11.3	14.0	4.5	8.5	6.8	5.7	7.1	7.4	9.8	15.6	8.3	17.9	18.5	3.9	5.1	8.2	7.4	15.4	3.4	13.0	31.1	17.1	22.9	10.8	6.7	9.5	8.5	7.1	5.0	11.5	9.1	10.8	4.2	5.0	3.4	4.5	6.7	12.8	12.5	6.6	6.1	10.5	7.4	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4	8.9	15.2	6.7	10.1	7.6	7.0	26.0	10.2	16.0	14.8	5.2	2.0	15.7	23.2	6.8	56.4	9.0	12.4	0.0	9.0	6.6	13.0	8.6	16.1	55.0	10.2	3.2	11.5	11.1	9.8	4.1	8.1	6.1	15.1	10.0	28.8	14.6	4.5	11.5	8.1	25.2	8.2	6.5	8.9	7.7	4.8	10.8	8.7	8.9	15.3	9.8
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 3.5;Hepatocytes: 2.6;Melanocytes: 5.0;Smooth muscle cells: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.8;HAP1: 38.9;HHSteC: 52.7;MCF7: 45.1;RPMI-8226: 43.1"									HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.4	3.9	5.1	20.0	11.5	7.4	40.8	8.0	2.0	3.3	3.4	12.0	0.3	0.0	4.3	15.0	0.0	0.4	38.9	2.8	0.6	0.0	4.9	2.7	15.6	14.4	52.7	1.6	3.8	4.5	0.4	3.6	3.2	3.0	8.8	18.9	30.1	22.7	2.5	45.1	2.8	0.0	4.8	14.6	6.8	0.0	0.0	43.1	0.1	3.6	10.6	15.6	17.4	1.0	7.5	4.3	6.2	20.4	1.2	0.2	10.0	0.1	0.8	7.9	6.3	9.0	3.7	2.4	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3	0.0	0.3	0.0	0.0	0.3	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 104.5"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 130.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 20.2;Karpas-707: 31.3;SK-MEL-30: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		25000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	2.2	8.3	2.3	1.0	3.2	2.2	2.0	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1.0	2.4	2.2	18.3	11.6	1.5	1.7	1.0	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1.0	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0.0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.1	0.7	3.5	4.9	4.3	2.4	7.8	2.1	1.9	1.8	7.8	1.4	3.2	2.8	1.6	1.5	4.6	2.4	13.5	1.4	3.6	8.6	3.0	3.3	2.6	4.4	20.2	3.7	0.8	3.7	12.2	3.7	4.3	0.7	1.6	5.6	6.5	31.3	1.1	1.4	1.3	0.8	3.6	1.9	2.7	1.3	1.9	7.8	3.6	0.0	1.9	1.6	3.2	3.8	40.8	6.9	1.3	2.1	0.5	0.6	4.0	2.8	1.9	12.1	7.1	1.5	4.8	7.7	1.4	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1.0	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3	6.0	3.5	5.6	6.2	2.3	6.8	1.6	5.1	0.0	1.2	5.2	9.8	0.6	10.0	1.6	14.9	2.0	11.9	0.0	3.5	1.3	2.8	5.2	0.0	130.7	1.0	0.0	2.9	4.3	2.9	3.4	1.1	1.3	18.6	0.0	5.9	4.3	6.4	11.0	3.9	22.0	10.1	0.0	5.5	1.6	0.5	1.8	0.7	4.3	4.3	2.8
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133345-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease mutation, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	12.1	7.6	9.8	20.2	10.8	31.9	11.5	27.1	14.4	12.0	8.6	10.0	4.3	8.1	12.1	8.0	12.0	11.5	7.8	8.0	9.3	8.1	6.9	9.2	11.8	29.7	12.5	7.9	11.1	6.2	10.2	8.8	32.5	8.7	8.3	10.7	7.8	9.3	6.5	6.8	10.8	11.3	11.2	9.1	11.0	9.0	19.9	12.6	31.4	9.5	8.8	28.8	11.4	9.7	12.6	19.0	10.2	13.4	25.0	18.2	6.8	24.3	15.4	19.7	16.7	7.3	7.5	42.3	16.5	13.1	23.8	23.9	14.9	13.3	40.8	10.4	10.1	12.0	16.1	21.7	12.9	24.4	16.0	32.3	59.1	13.8	7.7	3.2	24.0	24.0	5.0	2.5	20.8	8.2	7.2	12.9	12.6	23.4	25.2	17.7	16.2	35.1	32.8	25.9	11.0	22.5	35.6	20.7	22.4	7.5	15.4	21.0	16.3	20.0	9.0	6.4	12.6	9.4	12.2	9.7	40.0	13.7	24.2	24.4	20.6	21.5	48.3	11.6	22.4	31.0	10.2	13.4	3.3	18.2	13.2	15.9	7.9	14.6	12.5	11.3	12.6	16.6	12.3	3.1	25.0	7.9	19.0	12.9	6.8	9.8	10.8	27.1	14.4	9.3	8.1	12.5	7.9	8.7	12.6	6.0	24.5	38.8	19.1	26.3	66.8	11.9	7.6	48.2	29.6	21.0	53.0	329.4	11.6	20.3	42.9	33.0	4.7	93.5	12.4	56.3	25.7	12.5	34.8	12.1	68.9	62.0	15.1	24.5	28.2	38.6	25.9	51.5	13.5	45.1	16.3	39.9	15.7	11.5	26.9	7.6	50.4	12.9	22.0	249.6	179.2	19.6	270.7	54.2	37.6	14.1
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.1	3.5	14.9	3.6	1.6	1.2	19.5	1.0	0.9	2.0	1.6	8.8	5.7	0.0	2.2	1.9	1.6	1.0	1.6	2.2	1.2	3.7	2.6	6.4	5.3	10.5	3.9	1.3	4.1	3.6	1.1	2.6	0.9	3.9	8.3	14.5	7.3	1.4	1.5	8.5	13.9	15.1	25.7	5.9	1.9	25.4	16.4	2.1	1.2	1.5	8.8	31.3	1.2	8.4	2.6	13.4	1.0	6.7	2.8	2.5	3.3	0.6	1.3	3.2	2.2	8.6	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2	6.0	13.3	10.0	8.3	4.6	74.9	13.7	5.1	9.4	12.5	19.2	119.8	30.2	5.0	13.8	1.5	14.6	5.3	0.0	8.5	9.4	14.7	11.7	36.9	5.5	19.8	90.6	12.6	6.2	10.5	1.1	17.8	11.9	6.8	4.6	11.5	22.7	9.2	10.5	14.5	5.6	144.9	19.4	8.2	2.3	13.4	2.3	26.9	18.7	11.0	6.7
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell type enhanced"	"Detected in some"	7	"Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2"					"Low region specificity"	"Detected in some"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.0	1.4	0.1	0.5	55.3	0.7	0.5	0.8	0.8	20.8	0.9	2.1	2.2	0.3	0.9	0.5	3.9	0.3	0.6	0.2	3.1	21.7	0.7	3.9	0.2	0.9	2.2	0.5	0.4	1.2	0.2	0.4	1.4	1.3	20.8	0.6	0.3	3.3	3.3	18.4	74.7	1.9	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.2	1.3	1.9	0.5	41.2	1.2	1.1	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.5	5.9	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8	0.0	1.0	0.0	0.1	0.8	1.4	1.1	0.0	0.0	1.2	0.0	2.0	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.5	3.8	0.9	0.6	0.0	0.0	0.6	4.8	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.8	1.1	0.0	0.4	0.6	2.1	6.5	0.4	0.0	2.5	1.1	4.0	0.0	0.8	0.0
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 17.3;Proximal tubular cells: 13.5"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 31.2"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	4.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430562-82461091	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		140000	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	10.2	15.4	43.4	12.1	37.1	14.3	16.3	22.9	38.8	13.8	12.7	34.7	5.1	12.2	10.5	23.3	13.5	10.4	9.0	11.1	44.2	34.9	20.8	13.3	11.1	16.0	47.5	26.4	12.9	14.6	17.8	11.7	17.7	31.0	17.2	15.3	8.9	11.4	11.9	9.8	13.1	11.0	11.1	66.2	12.8	13.2	6.1	29.4	14.2	18.0	8.2	18.6	10.7	9.5	13.0	14.1	4.3	10.4	14.4	20.2	12.2	18.5	12.3	22.1	13.7	13.5	13.3	24.2	21.6	14.5	19.8	17.7	22.4	20.8	37.0	22.7	16.4	21.7	10.0	29.2	27.4	35.9	22.2	13.6	22.4	12.0	29.8	21.9	37.0	19.4	12.8	29.1	20.7	24.6	14.3	20.0	23.5	28.9	20.4	25.8	23.9	40.8	22.0	20.3	47.0	10.0	29.1	33.9	20.1	32.3	18.4	31.3	19.1	12.3	37.3	27.5	20.7	16.8	17.9	14.7	24.6	18.3	24.3	28.5	23.5	20.1	46.1	15.9	23.1	33.0	3.4	8.7	4.3	14.4	10.4	18.0	13.0	17.3	16.5	12.7	11.0	20.2	16.2	0.7	14.4	8.8	14.1	18.4	12.2	43.4	37.1	22.9	38.4	44.2	34.9	47.5	26.4	31.0	29.4	14.9	8.0	28.1	32.4	60.9	36.5	11.3	12.7	12.0	15.9	12.2	15.7	71.0	74.6	41.8	4.1	24.5	12.6	0.0	22.6	47.0	29.3	32.2	38.0	10.2	49.6	27.0	28.2	13.5	22.1	4.1	24.5	27.7	37.1	45.1	21.1	46.8	34.7	8.6	22.6	42.5	27.7	12.9	30.9	6.8	22.6	56.0	39.0	34.8	25.8	31.0
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192737-58205174	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 27.2;lymphoid tissue: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	41	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 5.5"	"Cell line enriched"	"Detected in some"	69	"NB-4: 74.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced					NA	NA					"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.1	0.1	0.3	0.2	0.8	27.2	0.1	2.0	0.6	0.1	0.1	0.5	0.1	0.1	0.4	0.1	0.1	0.2	0.1	1.4	0.3	0.3	0.1	0.2	4.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.2	0.6	0.1	0.0	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.2	4.5	0.1	0.1	0.1	15.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	2.0	0.6	0.3	0.3	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 398.1;Distal tubular cells: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	17.2	9.6	11.3	28.6	8.7	7.5	32.0	14.2	26.1	24.7	27.1	21.7	14.1	16.9	4.9	11.9	21.0	21.7	25.8	18.7	27.4	5.8	11.0	6.4	12.3	28.2	46.5	18.3	11.0	11.9	20.2	21.0	57.1	16.8	12.0	11.2	16.5	26.5	15.8	15.6	9.8	13.8	7.2	27.0	13.4	10.7	10.8	17.6	43.2	9.5	4.9	7.2	10.7	15.2	52.9	17.4	29.0	6.3	5.5	6.3	14.1	6.8	16.2	18.9	22.3	17.3	16.6	9.6	8.4	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7	14.9	14.4	29.9	39.5	10.5	86.5	398.1	96.8	26.8	14.8	69.8	58.9	29.8	203.9	43.4	86.1	13.5	75.3	46.7	27.1	14.9	9.9	11.6	32.2	145.9	26.2	71.5	18.9	17.2	11.6	9.5	10.3	9.5	47.2	14.4	30.8	29.4	25.5	30.3	13.4	123.7	55.6	12.9	14.1	28.9	11.5	9.2	46.1	12.1	50.2	36.7
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734357	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 167.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 269.3;Hepatocytes: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018139	Enhanced				"Intracellular and membrane"	NA	NA		7000000			"HPA018139: AB_1849903"	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	6.1	21.0	12.7	8.0	19.1	5.5	10.7	19.4	35.7	10.6	15.9	16.0	33.3	10.6	10.4	19.5	17.7	13.5	8.9	78.1	15.8	16.7	24.6	85.5	7.1	11.1	16.2	17.8	8.7	8.8	27.0	13.0	7.3	27.7	17.2	18.8	23.4	13.0	20.5	167.8	10.4	9.4	13.5	12.3	8.0	13.6	10.8	9.9	10.7	12.3	53.9	15.0	15.5	11.2	14.3	17.6	3.5	9.9	14.5	24.5	14.3	27.6	37.6	19.8	24.1	14.4	13.0	26.0	21.3	22.7	42.0	23.1	32.5	25.0	61.9	25.3	23.5	18.4	40.9	42.4	41.3	53.6	17.0	38.9	16.6	20.5	36.3	18.3	26.7	15.4	12.6	23.5	26.4	23.1	24.0	42.1	30.0	33.4	6.4	21.3	24.7	33.2	25.8	26.9	18.5	73.0	36.5	30.2	59.4	39.6	40.7	31.7	23.0	40.7	43.9	15.3	18.7	22.1	8.7	16.9	15.3	28.0	11.9	27.0	14.9	13.8	50.7	16.3	26.8	15.4	2.3	9.9	3.5	15.2	8.6	23.5	14.3	18.0	18.4	17.6	10.6	16.7	15.3	0.9	14.5	8.5	15.5	24.5	14.3	12.7	19.1	19.4	35.7	15.8	16.7	16.2	17.8	27.7	9.9	8.9	12.0	18.2	27.1	28.4	31.7	269.3	33.1	13.4	14.8	34.9	72.6	40.0	48.0	48.1	3.5	16.6	29.5	23.3	36.8	30.5	15.1	29.5	13.9	145.0	34.4	19.1	19.8	25.8	17.4	5.6	16.7	14.4	23.6	9.0	29.0	15.2	34.5	5.8	21.2	51.6	42.1	0.0	14.7	11.2	14.7	26.2	19.8	14.4	49.8	58.8
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.6;testis: 48.8"	"Cell type enriched"	"Detected in many"	12	"monocytes: 1188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 38.6"	"Group enriched"	"Detected in many"	6	"monocytes: 13.0;T-cells: 38.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	5.4	3.3	4.0	30.9	4.6	7.1	4.1	5.8	5.6	4.6	4.1	5.5	2.9	8.2	5.9	3.4	4.5	8.2	5.4	4.2	3.9	3.5	11.0	3.5	6.7	15.5	4.0	3.2	6.2	3.7	1.5	5.1	6.8	4.3	5.3	3.8	3.9	4.1	5.0	6.2	3.4	7.4	3.8	7.2	7.6	6.2	48.8	4.4	14.6	4.1	4.4	12.3	6.5	4.9	0.2	4.1	0.1	13.0	0.4	38.6	3.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.3	1.0	0.8	1.1	0.3	1.0	1.8	18.0	0.2	1.5	0.3	0.2	0.0	0.1	31.2	0.1	0.8	0.0	0.2	0.1	0.6	6.4	0.5	0.2	0.3	0.0	0.2	1.4	0.2	0.1	25.3	0.0	0.2	0.4	1.0	0.2	0.4	0.1	0.5	0.5	1.7	1.2	1.6	0.4	0.4	0.2	0.5	0.3	0.1	0.2	1.4	1.5	3.8	0.5	0.0	0.5	2.2	4.7	1.0	0.5	0.2	0.4	0.1	8.0	0.1	2.3	13.0	38.6	0.2	5.0	4.3	4.1	0.1	0.1	0.0	0.1	0.4	1.6	0.4	0.2	3.0	4.0	4.6	5.8	5.6	3.9	3.5	4.0	3.2	4.3	4.4	0.0	0.0	0.0	0.5	8.7	0.0	0.6	0.0	0.0	1.2	3.5	0.0	0.3	0.0	1.9	52.0	3.1	0.0	0.0	3.4	0.6	1.4	1.0	1.1	0.0	102.3	0.0	0.0	1.8	1.8	11.1	0.3	40.3	3.3	1188.5	0.0	0.1	0.5	0.0	0.4	1.6	0.2	0.0	2.1	11.9	2.5	7.2	0.7	5.0	0.1	1.4
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479600	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HL-60: 15.6"															NA	NA						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.4	0.6	1.4	0.2	2.4	1.9	0.1	0.2	0.4	0.0	0.9	0.2	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.4	0.2	0.2	0.6	0.3	0.7	0.7	0.4	0.0	0.4	0.2	2.2	0.2	0.1	1.9	0.3	0.3	0.2	1.5	0.8	0.0	0.3	0.4	0.4	18.9	0.0	0.1	0.8	0.0	0.1	0.2	0.2	1.3	0.7	3.5	0.5	1.6	1.9	0.2	0.2	0.4	1.0	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.5	0.9	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.7	1.0	0.6	0.9	0.5	0.0	15.6	0.7	0.1	0.3	0.0	0.2	0.2	0.0	1.0	0.4	1.2	0.1	0.3	0.4	1.1	0.4	0.2	0.7	0.8	0.4	1.5	0.1	1.1	0.6	0.5	0.5	0.3	0.2	0.5	0.4	2.2	0.8	0.6	0.2	1.0	0.3	2.7	0.6	0.2	0.3	0.6	0.3	2.1	0.4	0.4	1.9	0.3	0.3	0.9	0.5	0.5	0.7	1.3	1.1	1.0	3.5	1.6	0.5	0.5	1.3	0.2	0.6	0.6	2.4	1.9	0.4	0.5	0.3	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.6	0.0	0.0	4.6	3.6	0.0	0.2	0.0	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206823-59208515	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 56.6"	"Cell type enriched"	"Detected in some"	20	"Spermatocytes: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4"	"Region enriched"	"Detected in single"	6	"olfactory region: 1.7"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.4	0.8	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	103.7	0.6	0.0	0.0	0.0	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		780000000	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.6	87.5	77.0	50.6	55.2	61.5	89.5	45.6	45.6	63.8	63.2	138.5	0.1	115.5	29.9	30.7	62.2	16.4	105.9	84.5	81.3	29.6	73.7	118.8	83.7	0.1	52.8	110.9	51.4	70.3	30.3	55.9	76.1	75.5	72.7	83.7	64.9	17.4	70.1	0.1	94.2	134.3	222.1	53.5	38.0	85.1	107.5	93.1	316.6	145.6	24.8	57.4	20.9	32.5	78.6	213.4	0.2	87.0	28.3	43.0	56.4	30.5	85.8	15.4	20.8	151.7	47.6	53.2	51.0	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6	131.0	259.8	264.1	356.5	64.9	144.4	2212.6	252.3	329.2	235.4	450.1	64.8	1548.4	2801.9	8.8	8.2	201.1	10.6	163.5	278.5	675.2	313.9	183.2	261.1	6.8	514.5	133.5	88.8	124.0	155.9	19.6	254.3	185.3	170.4	154.1	114.8	173.5	149.2	14.4	390.3	2766.7	85.3	232.8	418.6	17.7	95.7	56.1	1371.1	274.1	316.8	307.0
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412307-18452058	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 143.9"	"Group enriched"	"Detected in some"	11	"Early spermatids: 838.5;Spermatocytes: 827.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 3.5;U-2197: 8.7;U-266/70: 7.8;U-266/84: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045442	Enhanced					NA	NA					"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.1	0.7	0.0	0.9	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	143.9	0.3	0.0	0.2	0.1	0.2	0.0	0.0	2.4	2.7	3.6	1.1	0.2	3.8	1.2	0.0	0.0	0.3	2.0	1.5	1.6	2.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.2	2.8	0.2	1.1	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.2	1.0	0.2	0.1	0.6	0.0	0.4	0.2	0.5	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.9	0.0	2.2	3.5	0.5	0.1	0.2	0.1	0.9	0.4	2.8	8.7	0.1	7.8	6.8	0.3	0.1	0.0	0.1	1.3	0.7	1.0	0.6	1.0	2.3	0.8	1.8	2.2	0.0	2.4	3.8	2.6	3.6	0.2	1.1	2.7	1.7	1.2	0.7	0.9	0.6	0.4	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	1.4	1.2	1.8	0.0	0.0	3.3	0.3	838.5	0.6	0.0	0.0	5.5	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.0	78.1	21.6	0.0	0.0	0.0	0.0	1.0	1.2	0.0	17.0	2.9	0.6	19.4	0.0	827.5	26.0	0.5	0.0	0.0	0.0	0.1
LPO	SPO	ENSG00000167419	Lactoperoxidase	P22079	17	58218548-58268518	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Antimicrobial, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	262	"salivary gland: 345.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.0;Late spermatids: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"THP-1: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA028688	Enhanced	Supported			"Secreted to digestive system"	NA	NA					"HPA028688: AB_10601909"	"unprognostic (2.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.41e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.8	1.3	0.7	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.0	1.5	0.0	0.9	0.7	0.4	0.6	0.3	0.5	0.9	0.7	0.6	0.2	1.2	0.6	0.9	1.3	0.8	0.3	0.8	0.4	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	1.1	0.0	0.2	1.6	0.0	0.6	0.0	10.6	0.3	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.4
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289684	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 178.8"	"Cell type enriched"	"Detected in many"	51	"Hepatocytes: 4835.7"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048627	Supported					NA	NA		530000			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.5	0.1	0.2	0.2	0.1	0.0	0.0	0.3	178.8	0.1	0.1	0.1	0.0	0.7	9.9	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	45.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	14.0	0.0	1.8	0.0	0.5	76.5	8.1	1.2	1.8	0.0	0.0	1.7	0.0	22.5	0.0	0.0	46.7	3.8	0.0	0.0	0.0	0.0	4835.7	0.1	0.0	0.0	88.4	94.8	4.2	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.1	2.4	0.0	0.0	0.0	0.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		950000	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	30.0	44.6	52.4	32.5	36.1	44.1	31.0	37.8	34.9	39.8	42.5	36.4	101.4	70.5	24.9	45.9	32.5	46.9	65.9	56.4	51.2	35.7	48.4	42.1	64.6	31.5	66.0	62.4	47.1	39.9	57.2	42.9	30.0	50.7	37.7	41.0	47.3	55.5	90.3	25.8	56.9	68.8	34.8	25.9	57.5	60.6	49.6	45.7	60.1	47.7	41.3	38.1	34.2	33.0	60.9	27.7	27.9	33.5	36.6	48.9	29.5	26.9	45.1	34.3	27.2	51.0	31.9	78.4	25.6	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4	44.7	76.0	36.8	172.0	127.5	81.9	4.5	86.6	34.8	63.7	68.0	64.8	30.7	16.6	50.4	46.3	49.1	61.0	23.3	49.9	34.3	63.9	55.3	83.1	40.6	57.5	25.4	79.9	36.2	106.8	20.7	66.7	92.6	64.1	35.1	55.5	59.7	55.5	42.1	78.8	119.6	80.9	109.9	101.9	51.4	57.7	103.4	31.9	36.2	51.7	86.6
MAT2B	"MATIIbeta, SDR23E1"	ENSG00000038274	"Methionine adenosyltransferase 2B"	Q9NZL9	5	163503114-163519336	"Predicted intracellular proteins"	"One-carbon metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037721, HPA037722"	Uncertain		Approved	"Plasma membrane"		NA	NA		1000000	"Plasma membrane"		"HPA037721: AB_10672389, HPA037722: AB_10671718"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-3)"	25.1	32.5	25.2	29.1	28.6	12.1	23.9	37.1	39.6	25.3	41.6	20.1	25.1	38.9	28.0	29.0	27.9	31.9	20.4	41.8	24.2	28.6	48.4	37.2	26.6	41.7	24.7	24.9	35.9	16.4	25.7	17.1	23.9	27.6	30.7	31.4	24.3	28.6	26.8	28.7	20.9	57.2	21.3	21.4	45.5	24.9	18.1	17.7	50.8	53.3	20.1	41.0	32.5	32.9	60.4	34.5	82.4	46.0	62.4	86.8	98.8	19.5	17.0	29.9	16.2	22.2	22.1	17.9	17.5	19.9	20.1	29.5	11.9	37.2	20.9	36.8	19.0	29.5	16.1	24.8	36.3	26.7	68.8	20.5	19.0	19.9	17.7	29.2	19.9	12.9	18.3	30.0	25.6	19.9	24.4	43.5	22.2	15.1	26.4	24.6	11.5	27.4	24.0	11.3	12.4	11.6	31.6	14.5	34.4	32.9	21.3	11.8	17.2	23.3	15.7	25.3	13.7	21.9	26.9	35.0	22.0	14.3	14.6	30.2	22.5	21.7	19.1	16.0	36.5	14.8	82.4	38.3	75.6	58.7	44.6	64.3	60.4	64.8	63.2	34.5	56.6	66.2	63.6	58.8	62.4	46.0	27.8	86.8	98.8	25.2	28.6	37.1	39.6	24.2	28.6	24.7	24.9	27.6	17.7	44.7	37.1	50.2	31.8	37.9	20.3	51.5	35.7	54.9	26.1	41.8	7.9	48.4	53.0	29.8	30.6	40.9	34.6	93.5	23.0	24.4	26.9	37.0	26.7	47.9	41.2	17.5	14.5	33.7	74.1	10.9	31.9	43.7	40.5	50.5	44.3	33.3	25.6	24.6	29.4	77.8	15.0	45.3	29.9	21.6	29.8	31.7	31.5	64.2	48.1	35.5
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.2	36.3	49.1	32.1	69.7	51.7	50.8	34.9	51.6	53.1	53.9	42.9	39.4	55.8	20.7	45.7	66.4	39.0	55.2	64.6	76.3	33.7	42.6	52.3	33.9	68.2	38.3	60.2	41.5	51.2	44.2	49.8	29.4	43.3	40.5	56.8	28.9	40.6	69.9	26.6	52.7	60.8	28.7	66.4	45.2	42.1	57.8	54.7	88.0	42.0	45.5	27.1	29.2	47.2	66.8	39.1	34.4	62.9	23.6	40.8	40.0	33.9	43.8	50.7	44.4	68.3	50.4	54.5	33.7	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2	56.6	41.7	76.8	91.9	72.5	153.0	1859.7	86.6	136.5	79.6	127.4	66.8	222.4	533.9	152.0	8.3	50.1	143.7	70.0	94.8	211.6	90.4	54.0	78.5	143.3	336.7	116.0	60.3	41.1	68.1	11.1	92.6	78.1	168.7	212.0	97.2	112.7	85.3	103.5	102.6	683.5	120.0	58.2	87.6	48.3	49.0	73.4	125.1	76.2	138.8	88.5
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765547	"Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.7;testis: 27.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 121.8;Early spermatids: 123.3;Spermatocytes: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.2;SCLC-21H: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved					NA	NA					"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.9	2.3	3.1	0.7	9.0	0.6	1.9	1.5	5.7	2.0	1.1	5.0	3.6	0.5	2.5	6.6	1.1	26.7	1.5	1.9	3.4	4.2	4.2	0.6	3.6	0.8	2.4	3.5	4.5	1.1	6.3	15.1	0.5	9.5	1.3	1.1	2.8	1.7	2.2	0.9	1.0	0.6	1.5	1.6	0.6	1.1	27.6	1.8	0.1	5.2	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	2.4	1.8	4.9	0.4	2.3	0.7	0.0	0.9	1.0	0.7	0.2	1.6	1.1	1.1	0.2	2.2	1.1	0.1	1.4	1.0	0.1	0.1	0.5	0.4	1.5	1.1	0.8	2.5	1.4	0.5	0.1	0.3	1.1	1.4	2.3	0.1	1.4	0.7	2.9	1.5	0.6	3.2	0.3	2.9	3.1	1.8	0.1	7.2	0.3	6.9	1.5	2.2	1.1	0.6	1.1	2.2	0.0	0.1	1.2	1.2	0.3	0.6	0.7	2.9	0.4	2.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	3.1	9.0	1.5	5.7	3.4	4.2	2.4	3.5	9.5	1.8	6.0	1.0	0.0	1.2	0.7	3.0	1.2	2.5	121.8	6.8	0.0	0.0	0.1	11.6	0.7	123.3	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	3.2	1.2	0.0	0.0	17.1	1.7	0.2	1.7	0.0	0.0	7.7	0.1	0.0	2.8	5.1	9.9	0.0	1.0	50.4	4.0	0.3	0.0	0.0	0.0	0.4
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	29.0	47.7	17.3	43.2	19.7	21.7	29.7	19.5	25.2	28.0	25.4	41.9	35.0	44.0	8.8	25.7	30.3	29.7	44.3	29.2	20.0	31.3	64.1	24.4	25.6	38.6	24.3	38.0	25.3	27.4	26.1	27.2	40.6	22.0	26.0	27.4	76.9	25.7	25.9	65.8	32.9	67.0	38.5	51.5	60.2	26.9	21.3	63.2	26.2	38.4	43.3	39.4	19.6	98.1	40.3	23.0	55.7	42.9	20.1	28.1	26.6	30.5	38.8	28.9	23.8	48.7	24.4	48.7	42.7	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5	47.6	54.0	113.9	144.7	120.7	61.8	448.3	122.3	80.3	48.9	109.9	17.7	283.1	379.7	210.0	208.8	86.2	316.5	0.0	291.5	257.6	93.5	138.9	53.1	240.8	220.1	68.3	162.9	73.1	117.9	127.9	92.0	117.1	172.1	171.3	226.5	63.6	223.7	228.0	93.3	301.0	48.8	84.1	129.5	71.9	69.5	145.2	246.6	109.1	306.4	194.4
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.3	17.0	8.3	17.1	9.8	6.1	13.2	7.8	7.1	8.6	11.5	16.2	6.4	22.6	11.4	5.6	5.7	10.1	7.2	11.4	1.2	13.6	40.3	8.7	7.4	38.0	31.0	9.4	12.2	10.6	22.2	5.6	5.2	7.9	17.3	11.2	15.5	6.6	2.3	11.1	0.8	32.0	15.7	18.8	17.7	24.3	9.9	16.8	8.6	4.7	4.2	32.0	5.2	8.3	14.9	4.4	8.9	15.2	13.3	7.4	21.0	8.1	5.3	11.6	5.3	6.8	2.6	11.5	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1	32.8	55.2	24.6	70.3	72.5	4.6	26.6	188.5	1.4	19.4	57.6	0.0	50.1	112.7	124.1	138.8	35.9	780.2	116.8	129.7	102.0	53.0	67.5	17.3	473.7	65.5	3.2	104.3	84.7	67.1	60.3	84.3	59.9	55.6	57.7	299.4	16.4	119.7	550.6	79.5	318.0	2.6	45.3	28.3	7.9	12.0	133.6	41.9	42.6	311.7	103.6
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764532-13774282	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		2600000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	14.5	18.5	12.5	21.8	18.3	16.6	16.8	24.5	21.8	21.5	17.2	23.6	23.5	19.0	24.2	21.3	20.7	19.9	17.6	13.5	14.6	12.1	24.4	20.1	15.4	19.5	16.5	14.3	24.0	20.5	21.3	17.3	24.2	17.2	17.8	13.4	18.5	23.4	21.6	13.0	28.6	18.5	13.3	16.6	22.0	19.8	5.0	16.7	20.0	21.8	10.5	18.2	18.1	20.6	5.7	8.9	6.9	5.8	5.0	6.6	3.6	10.7	8.0	4.0	9.6	4.4	8.2	9.8	12.8	7.4	11.6	10.6	8.4	8.6	5.8	5.1	4.7	5.5	18.1	18.6	13.2	7.1	10.1	32.2	4.6	12.7	9.0	3.9	13.9	10.8	8.2	7.3	5.9	4.7	10.5	10.7	5.7	8.8	0.3	5.0	15.8	15.4	8.9	6.6	3.9	22.9	14.5	5.4	13.1	5.9	8.4	8.0	7.2	4.6	10.5	10.0	5.6	8.2	5.1	6.5	6.0	5.5	21.2	6.2	7.9	8.3	1.7	5.1	16.1	7.1	6.9	5.5	1.9	6.2	5.8	6.0	5.0	5.3	6.6	4.7	5.7	4.3	3.3	4.1	5.0	3.2	8.9	4.8	3.6	12.5	18.3	24.5	21.8	14.6	12.1	16.5	14.3	17.2	16.7	8.9	16.6	10.8	9.0	9.8	3.1	0.8	5.1	20.1	14.8	15.7	7.9	10.1	5.0	8.2	0.6	6.0	9.1	0.0	11.0	7.7	8.5	6.0	12.7	9.0	6.3	1.6	8.7	12.3	8.9	1.4	16.1	8.5	1.7	6.4	9.4	3.3	5.8	11.0	14.2	8.1	6.3	25.8	5.5	0.4	3.9	9.9	4.5	14.4	9.1	8.0
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795281-236903981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 84.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044474, HPA054915"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA044474: AB_10966696, HPA054915: AB_2732589"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (8.10e-2)"	14.5	11.4	9.9	13.2	13.5	7.6	13.6	14.8	14.4	16.9	16.4	16.2	16.0	7.5	18.1	27.3	10.4	18.4	16.3	21.9	9.4	9.8	21.2	9.5	11.7	14.3	12.6	12.8	24.7	20.8	27.4	12.4	17.5	13.0	14.0	8.9	17.7	11.1	17.3	27.0	15.4	11.7	23.3	12.1	13.9	14.9	20.1	12.1	20.8	22.4	11.1	13.2	18.4	14.4	3.3	1.6	3.0	2.0	2.3	5.8	2.1	9.9	6.7	8.3	6.8	15.4	14.2	9.8	8.8	7.8	9.7	10.1	6.4	7.7	22.3	8.1	9.8	5.2	6.9	10.7	7.8	11.6	10.3	9.2	13.1	9.0	11.7	10.3	20.7	8.2	20.2	4.9	12.8	12.3	7.6	12.8	12.1	18.8	10.5	8.1	6.9	10.8	6.7	11.1	8.2	3.6	11.8	14.7	14.3	7.0	11.6	6.8	18.9	9.9	7.2	8.8	6.1	10.3	8.5	16.6	16.0	6.1	12.2	11.3	22.7	7.0	13.0	10.4	13.1	15.8	2.7	1.6	3.0	3.2	2.0	5.8	2.7	4.2	4.5	1.5	3.3	5.0	4.0	0.1	2.3	1.5	1.6	2.9	2.1	9.9	13.5	14.8	14.4	9.4	9.8	12.6	12.8	13.0	12.1	53.6	31.2	20.1	6.8	7.2	0.0	84.0	20.4	20.1	13.6	38.4	0.0	19.3	1.7	11.9	5.3	12.8	6.3	0.0	12.8	7.8	17.5	8.3	29.0	9.6	12.6	0.0	8.1	15.4	16.5	4.2	22.2	10.4	10.1	10.8	7.3	0.0	11.7	10.5	31.1	5.7	0.0	6.5	15.5	14.9	19.7	4.4	18.9	11.7	12.1	4.8
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.4	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.4	0.0	0.1	1.5	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.7	6.6	0.0	0.0	2.8	0.1	0.2	0.0	0.6	1.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	2.7	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.1	0.2	0.1	8.1	3.0	0.8	0.2	0.7	0.2	0.2	0.2	12.1	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1	3.0	3.4	0.5	0.8	1.3	0.4	2.4	5.1	1.4	4.5	12.2	0.0	0.9	6.6	1.6	4.4	0.9	10.4	0.0	3.6	1.6	0.6	0.4	0.0	18.8	1.0	0.0	6.9	1.3	2.6	2.2	1.4	4.2	0.0	9.0	2.6	0.9	3.7	3.2	0.7	14.6	0.5	0.0	1.0	5.5	1.5	0.6	0.3	1.5	3.3	0.6
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell type enriched"	"Detected in some"	47	"Hepatocytes: 399.2"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	399.2	0.0	0.0	2.9	8.0	8.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404863-95435329	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.0"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"myeloid DC: 22.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	17.0	42.2	54.1	7.5	59.1	3.3	23.1	25.4	52.2	16.5	24.0	29.7	7.4	28.2	16.6	22.7	10.2	15.0	18.9	13.1	57.2	31.4	23.9	81.0	33.1	4.5	41.4	31.0	10.6	7.2	10.9	15.0	34.3	34.8	14.7	31.1	9.9	8.5	17.2	4.3	19.4	19.1	18.4	44.2	7.3	8.8	9.6	40.1	1.8	13.6	5.1	11.2	13.7	8.1	0.9	22.1	0.5	5.2	5.0	3.5	3.0	9.6	60.7	49.4	26.7	6.9	15.3	13.9	19.8	23.2	15.4	16.8	13.7	22.2	0.0	27.8	19.5	29.6	6.5	9.0	15.2	17.6	0.1	11.8	4.9	36.5	45.2	11.0	0.0	6.8	22.1	17.6	8.3	11.3	31.6	31.9	0.0	3.2	0.2	45.4	8.8	0.0	5.4	9.7	25.9	14.1	0.0	23.3	2.3	47.7	7.6	3.4	10.6	28.2	31.5	19.0	29.8	9.3	3.2	34.7	23.2	16.9	7.8	19.0	5.2	6.0	0.0	21.7	4.5	30.2	0.0	5.2	0.5	3.5	2.6	3.1	0.9	1.3	3.2	22.1	0.4	1.9	2.4	0.0	5.0	1.2	5.3	0.6	3.0	54.1	59.1	25.4	34.3	57.2	31.4	41.4	31.0	34.8	40.1	119.1	85.8	10.2	37.2	14.9	3.9	25.4	71.4	37.5	67.1	80.3	0.0	66.3	8.3	132.9	1.4	51.7	71.3	70.0	44.3	257.9	23.1	23.4	13.9	127.1	35.6	36.5	12.1	36.8	21.8	2.0	15.0	30.4	106.3	20.8	37.6	174.2	71.8	87.7	20.5	39.6	7.9	19.4	40.1	1.9	5.5	14.1	42.1	9.2	65.6	18.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 460.4"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6.0	32.1	1.4	0.7	0.8	0.0	0.3	25.5	8.1	14.8	3.5	0.0	1.5	1.7	0.2	9.0	0.5	4.0	0.0	1.8	1.9	2.6	2.2	0.0	460.4	0.2	0.0	0.0	8.6	7.0	3.6	7.5	0.0	13.5	0.0	2.3	3.0	1.5	0.0	2.8	5.2	0.0	0.0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	52.1	16.0	26.6	29.5	103.2	50.5	22.5	106.5	36.3	44.5	31.6	30.2	35.1	33.9	34.1	87.2	16.4	30.5	34.8	34.3	36.2	29.8	32.1	22.5	27.4	34.1	58.2	23.5	7.4	41.8	34.8	24.4	34.2	28.0	43.6	14.2	50.0	7.0	50.5	10.7	15.9	31.0	58.5	28.7	99.6	19.1	30.8	34.6	66.6	11.9	12.4	23.0	36.7	43.2	24.4	40.0	36.5	33.2	29.3	17.3	19.9	26.2	28.9	10.6	15.7	27.9	20.8	20.5	15.8	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1	163.8	131.5	140.0	350.9	209.2	31.5	477.5	249.7	195.4	161.5	263.5	27.5	589.1	729.5	163.2	193.0	183.6	264.7	256.9	175.5	640.5	290.3	337.6	341.6	875.0	302.1	42.9	136.4	174.3	152.8	441.3	315.2	140.2	173.7	230.0	253.4	390.8	159.2	306.9	391.7	634.8	41.0	181.1	254.2	113.1	58.3	231.0	805.7	161.9	278.6	280.8
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 60.8"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 40.8;Ito cells: 86.5;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 57.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		4000000			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	36.4	3.2	2.6	13.1	2.0	0.5	60.8	0.3	3.7	15.5	17.7	2.7	5.1	4.3	20.4	8.9	7.4	9.7	12.9	16.2	2.0	2.6	5.8	6.9	14.3	8.5	1.8	1.4	19.2	2.1	1.5	6.5	18.3	3.6	15.2	5.0	7.6	7.3	6.8	8.4	3.7	8.4	41.0	2.6	13.7	7.8	5.8	1.2	4.3	5.9	4.8	3.4	26.3	20.1	0.5	2.0	0.0	0.0	0.0	1.1	0.1	6.6	2.3	12.6	0.0	35.7	32.8	9.6	39.9	31.7	17.5	19.2	0.0	0.1	0.0	57.3	39.4	0.8	1.4	0.0	24.5	22.3	0.1	0.4	0.0	24.9	0.0	35.4	0.1	0.0	36.1	7.2	19.7	14.9	53.1	42.9	6.2	0.0	0.0	24.7	3.9	1.1	1.3	10.2	0.0	9.1	2.2	44.1	0.1	20.5	0.0	0.0	23.3	0.0	12.9	0.0	26.4	4.7	0.1	41.6	28.9	14.3	1.0	30.7	0.0	33.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	2.0	0.0	0.1	2.6	2.0	0.3	2.7	2.0	2.6	1.8	1.4	3.6	1.2	6.0	2.9	0.0	2.3	2.6	1.4	5.3	7.6	2.7	0.0	1.8	0.0	0.6	0.0	7.9	33.3	40.8	0.0	0.0	0.0	7.7	15.2	12.9	1.1	0.8	1.6	0.0	1.7	86.5	9.7	24.5	24.7	1.1	6.8	1.0	0.8	11.2	0.8	0.0	14.2	0.0	0.7	45.3	26.2	1.8	10.1	2.5	1.1	0.0	0.0	1.0
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319578-51809445	"Enzymes, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"heart muscle: 59.1"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Group enriched"	"Detected in some"	7	"AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.1	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	7.9	0.4	0.1	0.7	59.1	0.2	0.3	1.0	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.8	1.1	0.3	0.9	0.2	0.2	0.1	0.2	0.3	0.1	5.2	0.0	0.1	0.2	2.5	0.3	0.2	0.1	1.5	0.3	0.3	0.0	0.0	0.1	0.0	0.7	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.6	0.1	0.0	0.0	0.0	0.0
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.8;intestine: 31.0"	"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 24.9;Undifferentiated cells: 21.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	10	"classical monocyte: 27.8;intermediate monocyte: 24.0;myeloid DC: 16.2;non-classical monocyte: 11.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.2;monocytes: 27.8"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 40.0;Hep G2: 54.8"									"HPA049500, HPA051051"	Supported					NA	NA		3200000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	1.4	3.8	5.6	4.3	4.9	7.5	2.5	14.0	6.3	2.1	6.7			31.0	2.5	4.5	4.0	3.7	2.0	1.7	5.6	5.2	6.6	10.1	3.8	3.2	4.3		2.9	4.3	8.1	8.0	3.0		5.8	6.1		5.3	5.2	1.5	5.6	17.9	4.0	3.4	5.7	2.7	2.1			6.4		5.8	3.6	2.4	1.5	16.2	1.4	27.8	0.4	2.0	11.2	4.9	10.3	10.3	7.1	9.4	5.4	13.7	5.5	4.6	5.5	6.2	4.3	40.0	5.0	29.0	5.2	3.7	12.9	10.6	4.3	5.4	4.6	7.6	4.0	14.1	54.8	3.8	3.3	9.4	7.6	7.0	6.0	2.1	12.3	6.3	7.0	1.2	31.6	3.7	15.2	2.6	20.9	6.0	10.7	6.0	11.2	4.1	9.1	7.1	4.4	4.0	5.3	1.5	16.2	2.4	3.3	6.1	7.4	2.4	10.9	5.3	8.0	3.2	9.4	8.7	3.1	3.9	5.8	6.4	1.4	27.8	0.1	2.0	24.0	0.3	1.5	0.3	0.6	16.2	0.3	0.3	0.3	0.4	0.4	11.1	0.2	0.3	11.2											11.9	8.1	5.2	1.9	1.8	5.0	1.5	5.1	2.7	11.4	0.0	7.9	4.6	0.0	2.5	1.0	4.5	15.0	0.0	3.6	2.1	2.0	2.8	1.1	2.4	1.3	1.6	1.2	3.1	3.5	0.4	0.9	2.8	1.7	3.6	10.7	2.6	4.3	24.9	1.8	0.3	5.7	0.0	2.0	0.6	0.2	2.4	2.5	3.2	21.1	1.6
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					NA	NA		26000			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.32e-5)"	12.2	25.4	11.9	6.4	13.3	7.5	11.9	9.7	21.3	12.4	11.8	18.8	15.4	12.8	14.5	22.2	14.1	16.0	13.6	18.9	10.5	9.8	26.8	43.4	10.5	7.0	14.2	15.8	16.1	13.5	45.6	11.9	7.6	15.2	17.5	11.7	17.5	17.4	25.0	25.9	7.0	10.4	12.9	11.6	9.6	13.4	5.5	14.4	3.2	15.1	13.4	11.4	16.5	9.6	1.6	10.0	17.6	11.8	9.2	4.6	7.1	4.7	14.0	8.9	14.4	15.1	6.5	20.5	5.6	6.2	8.0	5.6	13.6	10.4	0.5	9.7	6.7	5.4	6.3	7.0	7.0	4.5	21.1	4.7	7.2	8.4	16.3	5.8	0.1	13.6	10.3	3.0	6.7	4.9	12.0	18.8	0.7	12.9	9.9	8.3	11.5	0.2	4.8	4.0	7.3	10.2	6.4	3.7	10.0	8.9	9.4	4.5	5.9	9.9	21.6	8.0	9.1	35.0	8.8	9.6	4.1	5.3	5.1	3.8	11.3	9.7	0.6	7.1	4.3	6.1	5.9	8.1	17.6	0.1	11.8	0.0	1.6	0.7	0.0	10.0	0.2	0.5	0.2	3.2	9.2	9.4	0.2	4.6	7.1	11.9	13.3	9.7	21.3	10.5	9.8	14.2	15.8	15.2	14.4	8.9	10.4	1.4	3.2	1.1	4.6	19.7	12.7	5.3	13.6	14.0	5.9	25.0	14.9	4.4	0.5	5.2	6.7	0.0	5.5	16.5	5.1	3.2	4.6	41.5	9.0	9.5	5.8	6.7	4.9	0.7	4.0	5.3	1.7	11.8	7.3	7.7	4.3	7.0	8.5	25.1	8.0	6.5	3.1	2.1	0.9	1.9	25.7	2.2	6.8	1.7
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577130	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease mutation, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 387.0"	"Cell type enriched"	"Detected in some"	42	"Hepatocytes: 3069.2"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 2.4;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	7.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.7	0.9	0.0	0.1	0.3	0.1	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.5	0.0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.2	0.3	73.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	1.0	23.3	0.6	0.0	0.0	0.0	0.0	3069.2	0.0	0.0	0.0	53.4	61.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	0.0
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 178.4;Late spermatids: 342.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HSkMC: 16.2;TIME: 15.2"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA					"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.2	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.7	2.2	1.6	0.7	1.1	1.9	2.3	1.6	2.5	15.2	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	11.5	6.9	2.9	2.8	4.5	1.6	5.0	1.4	4.6	1.7	0.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	2.9	0.8	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7	3.0	21.9	3.0	19.5	15.9	9.2	3.0	0.0	5.3	9.1	7.0	5.9	1.6	1.7	3.0	178.4	13.0	1.0	0.0	2.8	59.8	10.3	5.3	33.5	3.0	13.8	7.9	13.8	16.5	57.3	342.9	13.0	14.6	8.5	1.8	1.9	3.8	5.2	14.4	6.7	2.1	6.0	6.5	4.6	2.8	9.6	18.6	7.2	8.7	1.6	9.6
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17142254-17202054	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved					NA	NA					"CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399"	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	6.1	4.4	4.4	8.5	7.7	4.0	6.3	14.0	6.2	5.3	3.8	4.2	4.7	4.1	7.5	14.4	3.9	6.8	5.1	5.0	4.9	4.5	6.7	2.7	5.3	5.3	4.3	2.9	9.6	5.0	12.8	12.6	5.1	6.2	5.0	3.6	8.0	5.6	3.8	4.3	4.4	5.0	5.4	5.1	5.9	4.2	4.2	6.1	19.9	11.5	3.3	5.7	4.0	5.2	6.1	10.5	5.2	4.4	3.5	8.0	3.6	5.0	2.5	10.0	2.5	3.8	2.2	0.0	4.4	3.2	4.6	5.5	4.2	4.2	3.5	0.6	4.9	8.8	2.6	6.7	4.2	5.4	7.3	4.3	5.2	3.8	2.5	3.3	3.4	3.9	3.0	2.6	3.1	2.2	4.3	6.1	9.5	6.4	3.9	7.7	1.6	16.9	0.8	6.2	1.4	2.8	3.7	7.8	2.2	2.5	2.8	2.6	3.3	0.0	1.9	3.3	5.0	4.8	3.1	3.5	3.4	7.2	6.3	5.1	5.0	4.7	8.8	4.3	4.8	3.3	5.2	4.4	2.4	3.9	2.5	7.2	5.4	6.6	4.9	5.5	6.1	8.0	5.8	2.8	3.5	1.4	10.5	2.2	3.6	4.4	7.7	14.0	6.2	4.9	4.5	4.3	2.9	6.2	6.1	6.0	3.7	0.9	1.6	3.0	12.4	3.6	2.5	6.7	7.9	3.5	3.9	1.9	5.0	3.6	5.0	5.0	1.7	23.3	4.2	2.0	4.0	1.3	12.7	0.5	4.5	15.9	0.0	3.1	4.8	4.7	6.1	4.2	0.0	1.8	1.2	16.5	2.2	1.4	6.0	3.7	18.5	0.0	2.9	12.6	3.6	2.8	1.5	5.0	2.9	0.7
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 203.8;Enterocytes: 300.1;Hepatocytes: 350.5;Paneth cells: 284.5;Proximal tubular cells: 229.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 16.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"OE19: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		2800000	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	8.5	29.7	6.0	13.5	7.6	5.7	6.1	5.0	10.5	9.5	38.4	12.9	10.9	37.4	5.9	4.0	16.6	6.8	38.4	14.1	5.1	4.9	19.7	102.1	6.2	3.2	8.2	7.0	7.2	23.9	1.8	2.3	5.0	5.9	8.1	21.6	6.2	13.6	6.9	8.3	5.4	39.5	3.8	4.7	3.5	22.8	3.3	6.7	1.8	8.5	12.8	10.5	7.2	9.2	1.6	16.0	14.3	11.5	2.2	1.2	5.2	11.1	24.9	3.1	10.6	7.7	3.0	5.9	6.2	5.3	3.6	5.4	7.2	7.3	3.0	5.2	4.9	3.5	9.6	2.3	6.2	0.8	8.7	13.9	3.1	4.7	14.0	19.2	4.3	7.4	5.9	7.0	2.7	2.3	5.1	8.8	1.6	3.6	5.2	1.7	25.6	0.1	13.9	5.4	73.6	10.9	10.0	3.4	5.2	10.2	10.5	1.8	4.8	6.5	11.8	8.4	3.2	12.2	10.9	6.6	4.1	7.7	6.8	1.9	3.9	3.9	0.9	1.5	12.4	2.4	5.3	11.5	4.9	0.6	3.0	1.1	1.6	0.5	0.4	16.0	0.8	0.3	0.2	14.3	2.2	0.8	1.1	1.2	5.2	6.0	7.6	5.0	10.5	5.1	4.9	8.2	7.0	5.9	6.7	26.8	66.9	14.5	10.5	1.1	0.8	32.5	203.8	21.4	19.4	19.2	0.0	9.5	39.7	35.3	1.4	5.0	300.1	0.0	38.8	6.0	15.5	9.3	13.9	350.5	13.2	1.6	33.0	36.2	24.7	2.7	12.0	8.3	1.7	17.2	154.8	25.4	33.8	284.5	7.4	229.1	0.6	0.0	3.6	0.7	0.1	2.0	9.5	10.9	155.4	15.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 272.3;Urothelial cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 144.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.2	103.7	12.1	11.3	58.1	32.6	42.0	41.4	26.2	18.7	19.4	10.9	33.2	16.7	19.3	144.9	70.2	7.8	23.8	15.9	22.2	8.1	10.3	14.1	81.4	46.1	93.3	21.9	15.4	18.5	16.4	41.4	13.2	57.6	64.1	23.0	19.3	7.9	28.0	10.7	22.4	10.0	11.6	44.8	106.9	22.3	8.4	14.5	21.8	12.3	18.8	11.4	33.5	53.0	33.0	23.9	12.5	13.0	85.6	9.2	19.1	20.6	33.9	8.7	17.0	25.1	19.3	12.2	54.4	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9	59.6	55.0	27.6	272.3	92.4	28.0	55.7	38.2	104.4	96.7	15.7	21.6	22.9	34.9	73.1	34.3	40.9	44.4	23.3	68.7	28.0	34.6	217.3	50.9	45.7	36.8	27.0	19.7	50.3	37.2	13.4	63.0	64.0	18.6	55.9	17.9	23.3	183.4	20.3	27.6	28.5	19.7	0.0	58.8	11.6	28.8	63.7	42.9	23.5	24.1	489.6
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA		410000	"Vesicles, Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.4	13.3	1.2	5.2	2.4	3.4	3.0	6.2	7.3	11.2	8.3	12.4	6.7	3.6	15.1	6.5	11.6	11.4	6.2	8.5	4.3	6.8	15.3	6.0	10.6	7.3	4.6	6.7	2.9	3.3	6.5	5.7	4.9	4.6	31.8	0.7	33.2	6.1	8.7	15.6	2.3	10.0	6.1	15.9	9.5	3.4	29.6	3.3	6.8	7.0	6.6	5.8	10.7	13.9	7.1	2.1	11.4	9.1	17.7	8.2	49.4	6.8	13.0	6.1	4.4	2.2	7.9	5.1	10.3	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8	14.9	27.1	5.2	19.2	3.8	20.0	13.6	17.8	13.4	10.3	19.2	9.8	51.6	49.7	18.7	21.0	11.3	13.5	0.0	27.8	19.6	12.5	19.5	1.1	47.4	23.3	9.5	1.2	10.4	20.5	14.1	14.4	12.1	5.0	25.2	12.1	19.0	19.9	14.0	8.5	44.0	9.5	6.5	9.1	8.6	12.8	4.5	35.1	11.7	14.7	12.7
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.2	11.1	5.3	5.1	17.2	15.4	5.1	10.0	14.1	13.3	12.9	4.6	2.6	2.8	5.6	11.8	11.6	14.3	4.7	10.3	15.3	8.3	6.3	4.1	5.2	5.1	7.7	6.3	6.2	10.6	11.0	6.5	9.3	9.5	12.4	0.2	3.1	2.8	16.9	6.9	0.2	2.1	1.4	14.2	11.5	1.0	12.2	3.5	16.0	14.6	2.2	4.7	11.0	14.1	8.8	6.8	11.2	3.8	9.3	12.3	6.5	20.4	9.8	0.6	6.3	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0	14.9	17.1	0.8	5.1	5.6	8.9	8.5	2.5	21.4	13.6	22.7	9.8	7.4	3.3	9.2	2.3	7.1	18.7	0.0	11.4	6.2	6.9	7.6	5.8	13.0	10.8	14.3	8.7	12.9	15.3	1.4	7.5	10.4	6.8	6.4	14.4	12.3	11.0	7.0	17.3	11.4	11.0	12.9	7.5	6.5	5.9	8.2	6.4	6.9	13.0	6.5
